SpringWorks Therapeutics
SWTX
SWTX was delisted on the 30th of June, 2025.
142 hedge funds and large institutions have $2.86B invested in SpringWorks Therapeutics in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 37 reducing their positions, and 11 closing their positions.
82% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 11
59% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 37
30% more call options, than puts
Call options by funds: $317K | Put options by funds: $243K
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
5% more funds holding
Funds holding: 135 → 142 (+7)
0.55% more ownership
Funds ownership: 91.21% → 91.76% (+0.55%)
22% less capital invested
Capital invested by funds: $3.69B → $2.86B (-$827M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$28.3M |
| 2 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$25.9M |
| 3 |
Jennison Associates
New York
|
+$25.6M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$23.8M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$20M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$77.1M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$68.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$49.3M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$8.54M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$6.33M |
SWTX Hedge Fund Activity: Q3 2021 in Review
142 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2021, worth a combined $2.86B — down 22% from $3.69B a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new SWTX positions and 11 closed out — a net gain of 9 holders — while 59 added to existing stakes and 37 trimmed.
The largest buyer was Bank of America, adding an estimated $28.3M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $77.1M.
- 142 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2021, up from 135 in Q2 2021.
- Funds reported $2.86B of SpringWorks Therapeutics stock for Q3 2021, down 22% quarter-over-quarter.
- 20 funds opened new SpringWorks Therapeutics positions in Q3 2021 and 11 closed out, a net change of +9 holders.
- The largest SpringWorks Therapeutics buyer in Q3 2021 was Bank of America, an estimated $28.3M added.
- The largest SpringWorks Therapeutics seller in Q3 2021 was Bain Capital Life Sciences Investors, an estimated $77.1M sold.
Based on aggregated 13F filings for Q3 2021.